Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
Year: 2015
Type: article
Source: Current Opinion in Rheumatology
Author: Philip J. Mease
Institutions: University of Washington, Swedish Medical Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: IL-17, IL-23, Th17 cells, psoriatic arthritis, psoriasis, ankylosing spondylitis, spondyloarthritis, IL-12/23 inhibitors, ustekinumab, IL-17A inhibitor, secukinumab, ixekizumab, brodalumab, IL-23 inhibitors, guselkumab, tildrakizumab, autoimmune disease pathogenesis, drug safety and efficacy
Open Access status: closed
OpenAlex ID: W2061205096
